Remove Containment Remove Drugs Remove Nurses
article thumbnail

So much for pharma earning trust back

World of DTC Marketing

The American Nurses Association, a national professional organization, said one-third of its members do not intend to take the vaccine, and an additional third are undecided. Vaccine makers like Inovio and Vaxart , which don’t have late-stage vaccine candidates, are still benefiting from the wave of investment.

article thumbnail

FDA Adds Quiz to Its Bad Ad Program to Combat Misleading Pharma Promotions

XTalks

Although the US Food and Drug Administration (FDA) doesn’t vet pharma ads, it has a “Bad Ad” program that now has an interactive quiz to help in the reporting of misleading information in pharmaceutical promotions. Moreover, the pharmaceutical industry spent more than $24 billion on drug promotion in 2017, of which $18.5

Nurses 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can you get Promethazine Cough Syrup?

Druggist

Promethazine: effect on the body Promethazine belongs to a group of drugs called antihistamines. Pharmacy-only drugs are not available for the public for self-selection; therefore, a request needs to be made in the pharmacy to purchase the required product. Adults and children over 16 years of age can use nigh Nurse liquid.

Nurses 52
article thumbnail

Best Over the Counter Sleeping Pills UK

Druggist

All of the non-prescription sleeping pills available in the UK contain sedative antihistamines. Over the counter sleeping pills UK: active ingredients All products available over the counter ‘for sleeping’ contain sedative antihistamines as the main active ingredient. Many factors can cause insomnia.

article thumbnail

U.S. FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™

Pfizer

FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™. FDA Extends Review of Pfizer’s New Drug Application for PAXLOVID™. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for its COVID-19 oral treatment, PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets).

Drugs 69
article thumbnail

Pfizer to Provide U.S. Government with an Additional 3.7 Million Treatment Courses of PAXLOVID™ to Help Combat COVID-19

Pfizer

In June of 2022, Pfizer submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of PAXLOVID for patients who are at high risk of progression to severe disease from COVID-19. The target Prescription Drug User Fee Act (PDUFA) action date for a decision by the FDA is in February 2023.

Drugs 110
article thumbnail

OncoHealth Expands Its Iris Platform for Digital Cancer Care

XTalks

During the pilot phase, 43 percent of members actively engaged with the Iris clinical team, which comprises nurses and mental health experts, with an average of 2.3 Under the Veris CCP program, cancer patients have access to a VerisBox containing Veris-branded Bluetooth-enabled connected healthcare devices. interactions per month.

Nurses 98